GGrantIndex
← Search

PHARMACOKINETIC EVALUATION OF TESTODERM TTS

$0M01FY2000RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

Abstract

The objective of the study is to determine and compare the pharmacokinetics of serum testosterone following application of a Testoderm TTS system from both a clinical lot and commercial lot. The study is a multi-centered, open-label, randomized, 3 period, baseline and 2 treatment crossovers, pharmacokinetic study with a washout period of at least 2 days. A newly manufactured Testoderm TTS patch (5mg) will be compared to an aged patch (stored for at least 18 months). Will answer whether release rate of drug is altered by storage.

View original record on NIH RePORTER →